The abstract is read at the publisher; the summary is JClub's.
Advances in surgical planning and molecular understanding are expanding the resectability of liver cancers, including hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
- Why it matters: Liver resection remains essential for curing primary liver malignancies, but challenges like cirrhosis and unresectability limit treatment options, necessitating improved strategies to increase surgical eligibility.
- What they did: The study discusses integrating surgical oncological principles with systemic and locoregional therapies, along with molecular insights, to downstage tumors and extend resectability in diverse hepatic tumor conditions.
- The result: These developments may enable more patients to undergo curative liver resections, potentially improving outcomes and broadening treatment options for liver cancer patients.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.